The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/Objective-Endocannabinoid levels are elevated in human and mouse atherosclerosis, but their causal role is not well understood. Therefore, we studied the involvement of fatty acid amide hydrolase (FAAH) deficiency, the major enzyme responsible for endocannabinoid anandamide degradation, in atherosclerotic plaque vulnerability. Methods and Results-We assessed atherosclerosis in apolipoprotein E-deficient (ApoE -/-) and ApoE -/-FAAH -/mice.
A therosclerosis is a progressive disease characterized by lipid accumulation, inflammation, cell death, and fibrosis within the artery wall. 1, 2 From the initial phases to eventual rupture of the vulnerable atherosclerotic plaque, inflammatory mediators play a key pathophysiological role. [2] [3] [4] Pathological studies revealed that the occurrence of acute plaque rupture and atherothrombotic clinical events (ie, myocardial infarction or ischemic stroke) depends on the plaque composition rather than the degree of stenosis. 1, 5 Vulnerable plaques are characterized by thin fibrous caps, a large lipid core, and increased inflammation. 5 The thickness of fibrous caps depends on the balance between extracellular matrix production through smooth muscle cells (SMCs) and degradation, because of matrix metalloproteinases (MMPs) secreted by inflammatory cells. 6, 7 MMPs have been described to destabilize vulnerable plaques by promoting angiogenesis, leukocyte infiltration, and apoptosis. 8 Moreover, an unexpected role for neutrophils in the pathogenesis of atherosclerotic plaque vulnerability has been recently identified. [9] [10] [11] [12] [13] [14] [15] Recent experimental and clinical data suggest that local and systemic elevation of endocannabinoid levels are linked with the development of atherosclerotic vascular disease [16] [17] [18] and coronary circulatory dysfunction in obese individuals, a precursor of coronary artery disease. 19 However, it remains unclear whether endocannabinoid levels might represent a risk factor or diagnostic biomarker for acute atherosclerotic vascular events. In fact, a causal role of increased endocannabinoid levels in atherosclerotic plaque vulnerability and occurrence of acute clinical events has not been investigated.
Endocannabinoids are lipids and belong to a physiological system that is further composed of the 2 known receptors, CB 1 and CB 2 , and enzymes for endocannabinoid biosynthesis and inactivation. 18 A major limitation for in vivo studies of the role of endocannabinoids in (patho)physiological conditions is their rapid metabolism, which led to the development of mice lacking the major anandamide-degrading enzyme, fatty acid amide hydrolase (FAAH), for studying the physiological functions of anandamide. These mice have strongly increased anandamide levels, in particular, in brain and liver, confirming the key role of FAAH in anandamide degradation. 20, 21 In this study, we interbred FAAH -/mice with apolipoprotein E-deficient (ApoE -/-) mice to assess the impact of FAAH deficiency on atherosclerotic plaque vulnerability.
Materials and Methods
For expanded methods, see the online-only Data Supplemental materials.
Animals and Atherogenic Diet
FAAH -/mice were in the C57BL/6J background 20 and crossed with ApoE -/mice to generate ApoE -/-FAAH -/mice. After backcrossing for at least 8 generations, 10-week-old ApoE -/and ApoE -/-FAAH -/mice were fed with high-cholesterol diet (HCD; 1.25% cholesterol, 0% cholate; Research Diets; D12108) and kept in conventional housing. All animal studies have been approved by the Swiss Federal Veterinarian Office and conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.
Blood Analysis
For measurements of differential blood cell counts (hematocytometer; Sysmex Digitana AG), serum cholesterol (Infinity, Thermo Electron Corporation), and triglyceride content (Cayman Chemical), blood samples were collected after overnight fasting before and after 5, 10, and 15 weeks of HCD.
Endocannabinoid Measurement
Endocannabinoids were extracted from 100 μL of mouse serum or 20 mg of heart tissue, and analyses were performed on a liquid chromatography-tandem mass spectrometry system, as described. 22
Histological and Morphometric Analysis
Atherosclerotic lesions were analyzed within the thoracoabdominal aorta and aortic sinus by Sudan IV staining for lipid deposition. Immunostaining was performed with the following antibodies: monoclonal CD68 (AbD serotec), CD3 (Pharmingen), Ly6G (Pharmingen), or polyclonal smooth muscle myosin (Biomedical Technologies), MMP-8, MMP-9 (both R&D Systems), and CXC ligand 1 (CXCL1) (KC/GROα, Santa Cruz Biotechnology). Apoptotic neutrophils were stained with the DeadEnd fluorometric TUNEL System (Promega), and counterstained with Ly6G and Alexa Fluor 594-labeled secondary antibody. Collagen was stained with 0.1% Sirius Red (Sigma Aldrich), and total collagen content as well as type I and III fibers were evaluated under polychromatic light or polarized light illumination, respectively.
Intravital Microscopy
Intravital microscopy of the carotid artery was performed in ApoE -/-Cx 3 cr1 egfp/+ mice, as described. 11 Therefore, mice were fed with HCD for 10 weeks and randomly assigned to receive FAAH inhibitor URB597 (1 mg/kg intraperitoneally; Cayman Chemical) or vehicle (2% dimethyl sulfoxide, 2% Tween-80 in saline) during the last 2 weeks of HCD. A phycoerythrine-conjugated antibody to Ly6G (clone 1A8, 1 µg) was instilled via a jugular vein catheter, 15 minutes before recording.
Flow Cytometry and ELISA
Blood was drawn by cardiac puncture, and bone marrow was obtained by flushing femurs. Both were subjected to red blood cell lysis. Harvested and dissected aortic arches were enzymatically digested. 23 Staining for flow cytometry was performed with the following antibodies: CD4-PerCP (RM4-5), CD25-PE (PC61), CD45-FITC (104), Ly6G-PE (1A8), and CD11b-APC (M1/70; all from BD Biosciences). FoxP3-FITC (FJK-16s) antibody was from eBioscience. Dead cells were excluded from analysis by labeling with 7-amino-actinomycin D (Invitrogen). All flow cytometry samples were collected and analyzed with the Accuri C6 flow cytometer and CFlow Plus Software (BD Biosciences). Granulocyte colony-stimulating factor in mouse serum was measured by ELISA (R&D Systems).
Splenocyte Stimulation for Cytokine Measurement
Murine splenocytes were isolated by homogenization and dissociation through 70-μm cell strainers, followed by red blood cell lysis. Cells (2×10 6 /mL) were stimulated in Rosswell Park Memorial Institute 1640 medium +10% fetal calf serum with plate-bound CD3 (10 µg/mL; 145-2C11; BD biosciences), and cell culture supernatants were harvested after 48 hours for quantification of interferon-γ, tumor necrosis factor-α (TNF-α), interleukin (IL)-10, and IL-17 by ELISA (R&D Systems).
Real-Time PCR
Messenger RNA expression of inflammatory markers (for extended description and primers see Table I in the online-only Data Supplement) was normalized to hypoxanthine-guanine phosphoribosyltransferase, and the fold induction was calculated by the comparative C t method.
Statistical Analysis
All results are expressed as mean (±SEM). Differences between probability values <0.05 were considered significant. Unpaired 2-tailed t test or 1-way ANOVA with Bonferroni's posttest was used.
Results

FAAH Deficiency Leads to Systemic Elevation of Its Substrates
In addition to anandamide degradation, FAAH is also partly responsible for the regulation of the levels of other N-acylethanolamines, which do not bind to cannabinoid receptors, but nevertheless can exert antiinflammatory or lipolytic effects via peroxisome proliferator-activated receptor-α, that is, PEA, and OEA, respectively. [24] [25] [26] Serum levels of anandamide, PEA and OEA levels were significantly higher in young ApoE -/-FAAH -/mice compared with ApoE -/controls ( Figure 1A-1C ). Their levels even increased in ApoE -/-FAAH -/under HCD, peaking after 5 (PEA) or 10 to 15 weeks (anandamide and OEA) diet. Conversely, the serum levels of the endocannabinoid 2-arachidonoylglycerol, mainly metabolized by FAAH-independent pathways, were only increased in ApoE -/mice with maximum levels after 10 weeks of HCD ( Figure 1D ). Comparable differences in FAAH substrate levels were found in hearts of ApoE -/-FAAH -/and ApoE -/mice (Table II in the online-only Data Supplement) .
Remarkably, absence of FAAH did affect total cholesterol levels in young mice (371.1±20.2 mg/dL for ApoE -/versus 218.3±23.2 for ApoE -/-FAAH -/-; P<0.001), whereas no difference was observed after HCD feeding ( Table III in the onlineonly Data Supplement). We also analyzed triglyceride levels after 10 weeks of HCD, which were comparable. However, we found a significant difference in body weight between both genotypes in young mice (22.0±0.4 g for ApoE -/versus 24.8±0.3 g for ApoE -/-FAAH -/-; P<0.001) that was again no longer found after HCD.
FAAH Deficiency Leads to the Development of Smaller Atherosclerotic Plaques
Within each genotype, plaque sizes significantly increased with duration of HCD. However, the comparison between both genotypes revealed that plaque areas in descending thoracoabdominal aortas were substantially (≈50%; P=0.007) smaller in ApoE -/-FAAH -/mice after 15 weeks of HCD (Figure 2A ). Similarly, we found smaller plaque areas in aortic sinuses of ApoE -/-FAAH -/mice compared with ApoE -/mice after 10 to 15 weeks of HCD (P=0.01 or 0.027, respectively; Figure 2B ).
Plaques in FAAH-Deficient Mice Have a More Vulnerable Phenotype
The cellular composition of atherosclerotic lesions rather than plaque size appears crucial in both atherogenesis and plaque rupture. We therefore assessed the effect of FAAH deficiency on atherosclerotic lesion quality by immunohistochemical analysis of aortic sinus cross sections. Although the content of macrophages was comparable between the 2 genotypes at all time points ( Figure 3A ), the number of T-lymphocytes was significantly (1.7-fold; P=0.019) reduced after 10 weeks in ApoE -/-FAAH -/mice compared with ApoE -/mice ( Figure  3B ). At the same time point, we found a significantly higher neutrophil content (P=0.02) in plaques of ApoE -/-FAAH -/compared with ApoE -/mice ( Figure 3C ). High neutrophil infiltration is strongly associated with features of vulnerable plaques. 12, 14, 15 Conversely, the content of SMCs, which reflects plaque stability, was reduced by 36% after 10 weeks of HCD (P=0.01; Figure 3D ).
We further assessed the expression of proteases, which are released by infiltrating inflammatory cells within plaques of ApoE -/and ApoE -/-FAAH -/mice. The expression of MMP-9, an enzyme involved in the degradation of plaque-stabilizing matrix protein, was increased by 73% (P=0.049) in ApoE -/-FAAH -/mice compared with ApoE -/mice ( Figure  3E ). MMP-8 expression was weak and not affected by FAAH deficiency ( Figure 3F ). Despite the increase in MMP-9 expression, the total plaque collagen content was unchanged (P=0.9; Figure 3G ). In addition, the plaque composition of collagen type I and type III fibers was comparable between the genotypes.
MMP-9 Expression Colocalizes With Plaque Neutrophils
To confirm the role of neutrophils in plaque vulnerability, we verified the cellular source of plaque MMP-9 expression by double immunofluorescence staining. In both ApoE -/and ApoE -/-FAAH -/mice, MMP-9 mainly colocalized with neutrophils rather than macrophages, and the staining mostly appeared intracellularly ( Figure I in the online-only Data Supplement).
Increased Proinflammatory Cytokine Expression, but No Increase of Ly6C hi Monocytes in FAAH-Deficient Mice
Despite the predominant evidence for increased plaque vulnerability in ApoE -/-FAAH -/mice, the reduced T-lymphocyte counts revealed by immunohistological analysis ( Figure  3B ) are puzzling. A potential explanation for the difference in plaque T-lymphocyte numbers might be a modulation of T-lymphocyte subtype commitment in FAAH-deficient mice. After 10 weeks of HCD, we found a significantly reduced number of CD4+ effector T-cells and FoxP3-expressing regulatory T-cells in spleens of FAAH-deficient mice ( Figure 4A ). Concomitantly, in vitro stimulation of splenocytes with platebound CD3 revealed a significantly increased production of Th1 cytokines interferon-γ and TNF-α, whereas IL-10 production was unchanged ( Figure 4B ). In addition, we observed a nonsignificant tendency for increased IL-17 production (P=0.12).
We further assessed the percentages of circulating and aortic arch Ly6C hi -expressing monocytes, which were comparable between ApoE -/and ApoE -/-FAAH -/mice after 10 weeks of HCD ( Figure II in the online-only Data Supplement).
Increased Neutrophil Counts in Aortas, but Not Peripheral Blood and Bone Marrow
Hyperlipidemia has been shown to induce neutrophilia in mice because of enhanced granulopoiesis and mobilization from the bone marrow. 11 To verify the hypothesis that the increased neutrophil plaque content might be a consequence of systemically increased neutrophil counts, we assessed neutrophil counts in peripheral blood, bone marrow, and enzymatically digested aortic arches. However, the flow cytometric analysis did not reveal a difference in circulating and bone marrow CD45+CD11b+Ly6G+neutrophil counts between the 2 genotypes. Conversely, the number of neutrophils was significantly increased within aortic arches of ApoE -/-FAAH -/compared with ApoE -/mice ( Figure 5A ), confirming our immunohistological findings ( Figure 3C) . No difference in granulocyte colony-stimulating factor serum levels was found ( Figure 5B ), suggesting that FAAH deficiency does not affect granulopoiesis.
Another possible explanation for the increased neutrophil plaque content in ApoE -/-FAAH -/mice could be reduced cell death. However, we did not find a difference in the number of TUNEL+ apoptotic neutrophils within the plaques ( Figure  5C ), suggesting that rather enhanced recruitment of neutrophils might account for their increased numbers in aortic root plaques and arches. To support our hypothesis, we performed intravital microscopy in HCD-fed ApoE -/-Cx 3 cr1 egfp/+ mice carrying fluorescent monocytes. To visualize neutrophils, an antibody to Ly6G was instilled intravenously ( Figure 5D ). Treatment of mice with the selective FAAH inhibitor URB597 significantly increased the number of adherent neutrophils along the carotid artery ( Figure 5E ), whereas the number of adherent monocytes was comparable between URB597-and vehicle-treated mice ( Figure 5F ).
FAAH Deficiency Does Not Affect Neutrophil Secretion and Migration In Vitro
The enhanced neutrophil recruitment in plaques of ApoE -/-FAAH -/mice might be a consequence of altered cellular responses to inflammatory activation. To test this hypothesis, we performed in vitro experiments with freshly isolated neutrophils from ApoE -/-FAAH -/and ApoE -/mice. No difference in chemotactic migration was found, and chemokine-induced MMP-9 release and proteolytic activity was comparable between the 2 genotypes (Figures III-V in the online-only Data Supplement).
Local Increase of the Neutrophil Chemoattractant CXCL1 in FAAH-Deficient Mice
We further determined transcript levels of neutrophil chemoattractants in abdominal aortas after 10 weeks of HCD by real-time PCR. We found a 1.9-fold increased mRNA expression of CXCL1 (P=0.004), and a nonsignificant 1.5-fold increase of CC ligand 3 (P=0.1) in ApoE -/-FAAH -/mice ( Figure 6A ). TNF-α and CXCL2 levels were not affected by FAAH deficiency. Similarly, mRNA levels of chemokine receptors CXCR2 and CXCR4, as well as E-selectin and P-selectin were not significantly different ( Figure 6B ). Systemic chemokine levels were comparable between the 2 genotypes after 10 weeks diet (Table IV in the online-only Data Supplement), which supports the hypothesis of locally increased CXCL1 chemoattractant release that favors neutrophil infiltration in plaques of ApoE -/-FAAH -/mice. We confirmed the local CXCL1 chemokine expression by immunohistochemistry, which appeared more pronounced in plaques of ApoE -/-FAAH -/rather than ApoE -/mice ( Figure 6C ).
Discussion
Emerging evidence suggests an activation of the endocannabinoid system in various pathophysiological conditions, including atherosclerosis. 18, 27 Increased systemic endocannabinoid anandamide and 2-arachidonoylglycerol levels have been found in coronary artery disease patients, as well as increased CB 1 immunostaining in lipid-rich plaques, as compared with fibrous plaques. 17 Moreover, we reported presence of endocannabinoids and their receptors (mainly CB 2 ) in human carotid plaque specimens. 28 In agreement with the published human data, 17 we previously demonstrated a modulation of endocannabinoid levels during atherosclerosis development in mice. 16 This may have functional relevance, given that CB 1 antagonism with rimonabant reduced atherosclerosis in low-density lipoprotein receptor-deficient mice. 29 However, it is difficult to dissect the cardiometabolic effects of this drug from its antiatherosclerotic effects, and it was shown to mediate, in part, antiinflammatory effects independent of CB 1 receptor blockade. 29 Thus, clear evidence for a causal role of enhanced endocannabinoid tone in atherosclerosis is missing. This prompted us to clarify the involvement of enhanced FAAH substrate levels by genetic deficiency in the ApoE -/mouse model of atherosclerosis. We used knockout mice with genetic ablation of the anandamide-metabolizing enzyme FAAH that have elevated endocannabinoid anandamide levels in brain and peripheral tissues. 21, 30 These mice exhibit reduced pain sensitivity and an antiinflammatory phenotype. 30, 31 Conversely, in a model of doxorubicin-induced cardiotoxicity FAAH -/mice developed increased myocardial injury. 32 A limitation of the FAAH -/model is certainly that FAAH has the capacity to metabolize a range of substrates, including PEA and OEA. Nevertheless, to the best of our knowledge, there is no loss-of-function mouse model with impaired anandamide synthesis available. In fact, at the level of anandamide (and related N-acylethanolamines) synthesis, alternative pathways appear to exist, given that genetic deficiency of enzymes involved in endocannabinoid synthesis does not impair N-acylethanolamines synthesis. 33 The elevated systemic and cardiac levels of FAAH metabolites in young ApoE -/-FAAH -/mice compared with ApoE -/mice confirm the major role of FAAH in the metabolism of anandamide, PEA, and OEA. The further increase of their serum levels under HCD feeding suggests that additional mechanisms, such as increased synthesis, may account for this observation. However, the finding that an increase of the endocannabinoid 2-arachidonoylglycerol (which is mainly metabolized by monoacylglycerol lipase) only occurred in ApoE -/-, but not ApoE -/-FAAH -/mice receiving HCD suggests a regulatory cross-talk between the different metabolic pathways. Enhanced levels of FAAH metabolites may trigger alternative metabolic pathways, such as cyclooxygenase-2, which counteract increases of 2-arachidonoylglycerol levels in mice developing atherosclerosis. Importantly, we previously demonstrated that the increase of endocannabinoid levels in HCD-fed ApoE -/mice was paralleled with atherosclerotic plaque progression and was not solely a diet-mediated effect. 16 The observed differences in weight and serum cholesterol levels at young age might be explained by the well-described effects of endocannabinoids on food intake and lipid levels in experimental and clinical studies. 34 It is likely that these metabolic differences in young mice do not have a major impact on atherosclerosis development, as these differences were no longer found after 5 to 15 weeks because HCD feeding. Moreover, it was previously shown by Dol-Gleizes et al 29 that low-density lipoprotein receptor-deficient mice with reduced weight gain because of food restriction develop atherosclerosis comparable with ad libitum fed mice.
ApoE -/-FAAH -/mice developed smaller plaques with an unstable phenotype, which is evidenced by the increased number of neutrophils and enhanced MMP-9 production, together with lower contents of SMCs. Conversely, the plaque macrophage content and Ly6C hi/lo ratio was unaffected. Surprisingly, the ratio of plaque collagen type I to type III fibers was unchanged. We even found a nonsignificant tendency for increased total collagen content in ApoE -/-FAAH -/mice (P>0.09), which might be related to a profibrotic effect of endocannabinoids. This is supported by previous findings in experimental models of liver fibrosis and diabetic cardiomyopathy. 35, 36 Although MMP-9 is involved in extracellular matrix degradation, Sluijter et al suggested that MMP-9 could not be solely responsible for plaque vulnerability, as intact collagens are not substrates for MMP-9. They found that both MMP-8 and MMP-9 are associated with vulnerability of human carotid plaques. 37 We may also speculate that MMP-9 is mostly stored in neutrophil granules rather than secreted to the extracellular space, which is supported by the double immunofluorescence analysis of MMP-9 and neutrophil marker Ly6G.
Neutrophils have been detected at the sites of plaque erosion or rupture on atherectomy specimens from patients with unstable angina, and on autopsy samples from patients with acute myocardial infarction. 12 Accordingly, high neutrophil numbers have been recently associated with features of rupture-prone carotid plaques, that is, large lipid core, high macrophage numbers, and low collagen amount and SMC numbers. 14, 38 Presence of neutrophils in murine atherosclerotic plaques has been confirmed in various experimental studies including our own. 28, 39 Among other possible proatherogenic mechanisms, neutrophils have been recently shown to deposit cathelicidins (in mice known as cathelin-related antimicrobial peptide, [CRAMP]) on inflamed arterial endothelium, thereby promoting the recruitment of inflammatory monocytes. 40 Increased numbers of plaque neutrophil infiltrates have been attributed to hyperlipidemia-induced granulopoiesis and mobilization from the bone marrow. 11, 15 However, our flow cytometry and immunohistochemistry data suggest that increased neutrophil plaque contents in FAAH knockouts are rather a consequence of increased recruitment to atherosclerotic plaques than to enhanced granulopoiesis. In fact, circulating and bone marrow neutrophil numbers were comparable after 10 weeks of HCD in both genotypes, and no difference in serum levels of the granulopoiesis-stimulating factor granulocyte colony-stimulating factor was found. We excluded the possibility that the increased plaque neutrophil content was a consequence of altered apoptotic cell death, and we did not find a difference in neutrophil migration and MMP-9 secretion in response to inflammatory activation in vitro. However, the in vitro stimulation response was moderate in our experiments, possibly because of a preactivation state of To discriminate between monocytes and neutrophils a phycoerythrine-conjugated antibody to Ly6G (clone 1A8, 1µg) was injected. Quantification of adhesion of neutrophils (E) or monocytes (F) in mice receiving vehicle or the FAAH inhibitor URB597 during the last 2 weeks of HCD (n=6). **P<0.01. February 2013 neutrophils induced by the peritoneal lavage isolation. In the same context, we cannot exclude the possibility of increased intracellular MMP-9 storage or enhanced synthesis of other neutrophil secretory proteins, such as CRAMP, in FAAHdeficient neutrophils. Nevertheless, the in vivo imaging confirmed that impaired FAAH activity results in specific recruitment of neutrophils, but not monocytes, to large arteries, suggesting a neutrophilspecific vascular activation pattern. As a possible mechanistic explanation, we found that the neutrophil chemokine CXCL1 was upregulated in aortas of ApoE -/-FAAH -/mice, suggesting that increased local synthesis of CXCL1 contributes to the enhanced influx of neutrophils in plaques of ApoE -/-FAAH -/mice. This is possibly linked to the proinflammatory Th1 cytokine pattern, as a result of reduced numbers of regulatory T-cells in FAAH-deficient mice.
A recent in vitro study reported that IL-17 and TNF-α synergistically mediate sustained neutrophil recruitment to activated endothelium, via specific induction of neutrophilic chemoattractants (including CXCL1) and adhesion molecules. 41 Thus, the 2.6-fold higher TNF-α production and 1.6-fold (nonsignificant; P=0.12) induction of IL-17 in FAAH-deficient mice might trigger increased CXCL1 expression within atherosclerotic plaques. A limitation of our study is that it remains unclear whether the smaller plaque size in ApoE -/-FAAH -/mice is a consequence of the lower SMC content as well as the high amounts of neutrophil proteases within the plaque, which is likely to induce extracellular matrix degradation. Although there was no difference in plaque collagen content, the proteolytic activity could affect other extracellular matrix elements, such as elastin and proteoglycans. The reduced SMC content might be a consequence of reduced migration and proliferation or enhanced necrosis/apoptosis, which deserves further investigation.
In conclusion, our data suggest that enhanced levels of FAAH substrates (such as anandamide) trigger the development of small plaques with high neutrophil and reduced SMC content, and thus increased risk of rupture. Thus, we may speculate that increased endocannabinoid anandamide levels found in patients with coronary artery disease might increase the risk for developing an acute clinical event because of plaque rupture. 
